Veeva Systems Stock

Veeva Systems Equity

The The Equity of Veeva Systems (VEEV) as of Aug 6, 2026 is 7.21 B USD. In the previous year, The Equity was 5.83 B USD — a change of 23.70% (higher).

Equity

7.21 BUSD

YoY

23.70%

Last updated:

In 2026, Veeva Systems's equity was 7.21 B USD, a 23.70% increase from the 5.83 B USD equity in the previous year.

Access this data via the Eulerpool API

Veeva Systems Stock analysis

What does Veeva Systems do? The history of Veeva Systems Inc: Veeva Systems is a leading company in the field of cloud software for the life science industry. The company was founded in 2007 and is headquartered in Pleasanton, California. Veeva was created by Peter Gassner and Matt Wallach to improve the management of clinical trials and collaboration in the pharmaceutical industry. Business model of Veeva Systems Inc: The business model of Veeva Systems is focused on improving efficiency and collaboration in the life science industry. The company offers cloud-based software solutions tailored to the needs of life science companies. These solutions include CRM systems, clinical trial management software, data management tools, and analytics tools. Veeva Systems was founded as a CRM company for the life science industry. With its first software, Veeva CRM, the company revolutionized how pharmaceutical companies manage and collaborate with their sales forces. Since then, Veeva Systems has expanded its portfolio and offers a wide range of software solutions, ranging from planning and conducting clinical trials to collecting and analyzing data. Divisions of Veeva Systems Inc: Veeva Systems is divided into three divisions: 1) Commercial Cloud: This division of Veeva Systems provides software solutions for managing customer relationships, sales and marketing activities, and digital marketing for life science companies. 2) Vault: The Vault division of Veeva Systems offers software solutions for managing content, data, and processes involved in clinical trials and other research projects. 3) Data Cloud: This division offers analytics and data management tools that enable life science companies to collect, manage, and analyze their data. Products of Veeva Systems Inc: Veeva CRM: A CRM software solution that allows pharmaceutical companies to control and manage their sales and marketing activities. Veeva Vault: A suite of software solutions that facilitate the management of clinical trials and research projects. Vault provides solutions for electronic data capture, electronic informed consent forms (eICFs), clinical data management, and document management. Veeva Network: A cloud-based platform that enables life science companies to simultaneously collect patient data and advertise for it. Veeva OpenData: A database of contacts and companies from the life science industry that is regularly updated. Veeva Align: A tool for optimizing personnel deployment and ensuring compliance in the sales of life science companies. Veeva Vault QualityOne: A platform for managing quality control processes, including supply chain monitoring, compliance with regulations, and ensuring standards. Conclusion: Veeva Systems has positioned itself as a leading provider of cloud software solutions for the life science industry and offers its portfolio of CRM, clinical trial management, data management, and analytics tools. The company has succeeded in improving collaboration in the pharmaceutical industry by leveraging cloud technologies to increase effectiveness, safety, and compliance. Veeva Systems is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Veeva Systems's Equity

Veeva Systems's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Veeva Systems's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Veeva Systems's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Veeva Systems's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Veeva Systems’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Veeva Systems stock

The Equity of Veeva Systems is 7.21 B USD in 2026.

The Equity of Veeva Systems changed from 5.83 B USD to 7.21 B USD, representing a 23.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Veeva Systems since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Veeva Systems historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Veeva Systems

All Key Metrics — Veeva Systems